First Pavlov State Medical University of St. Petersburg was where Mikhail Blagosklonny shaped his career. He pursued both his M.D and PhD degrees in this institution. He began with a degree in internal medicine and later studies experimental medicine and cardiology. Among his first promising opportunities were being an associate professor at New York Medical College and joining Ordway Research Institute as a senior scientist. In 2009, Mikhail joined Roswell Park Cancer Institute and became the professor of oncology. Know more about Mikhail at Philly Purge.
Apart from his interest in oncology research, Mikhail also focuses on aging. He enjoys studying mechanisms of aging and how to manage it. In some instances, he finds connections between cancer and aging. For example, Mikhail developed a hypothesis that TOR signaling has a role in aging and cancer. He recommended the use of rapamycin, which is a cancer drug. According to Mikhail, rapamycin extends life.
Mikhail’s goal is not just to avail cancer treatment. He would also like the treatment methods to be efficient. Patients do not have to experience excruciating pain and paying high costs for treatment. He also wants the treatment processes to kill cancerous cells without destroying the normal cells. These cells are important in recovering the body after the entire treatment is over.
Besides being a professor and researcher, Mikhail Blagosklonny is a philanthropist with a humble personality. He aspires to ensure all people will have the best treatment, regardless of their income. One way Mikhail is impacting the world is in his position as the editor in chief of Oncotarget. It is the largest database of peer-reviewed journals in the world. These journals are on medical research of oncology and a few other areas. Read Mikhail’s plans for Oncology on Healingmagic.net.
Mikhail’s contribution to medicine is great, and it has made a positive impact. He has been mentoring others and working closely with other peers in the medical field. Mikhail believes in sharing information and combining it to establish progress. He also believes in networking and learning from others. The field of medicine is not an area anyone can succeed alone. Every viable contribution plays a role in the big picture.
It should not end with Mikhail Blagosklonny. After he retires from medical research, Mikhail would like other people to pick up the mantle and continue with the work. Cancer is a dangerous disease, and people should not stop fighting it until is completely under control. In the future, receiving cancer treatment will not be seen as an opportunity for the rich only. Every individual needing it will have access to quality healthcare.